Searched for
BSE OBSERVATION LETTER
Suzlon Energy shares crack 5% after Rs 29 crore Sebi fine for misleading financials; company clarifiesSuzlon Energy shares 5% dipped after Sebi imposed nearly Rs 29 crore in penalties on the company and former executives for misrepresenting ...- RBI scraps Paytm Bank licence; Pronto's back-to-back fundingRBI has cancelled Paytm Payments Bank licence over compliance lapses. This and more in today's ETtech Top 5.
- SFIO widens probe into IndusInd Bank; summons audit firms over ₹2,000 crore derivatives irregularitiesThe Serious Fraud Investigation Office is investigating IndusInd Bank's derivatives portfolio. Major audit firms associated with the bank o...
- Dabur receives 'no adverse observations' from BSE on merger of Sesa CareHome-grown FMCG firm Dabur on Friday said it has received an observation letter with "no adverse observations" from the BSE over its Scheme...
- BSE, NSE warn Suzlon for LODR non-complianceSuzlon Energy has been issued an advisory cum warning letter from both the National Stock Exchange (NSE) and BSE Ltd, regarding non-complia...
- No adverse observations from bourses for proposed merger, says HDFC BankThe bank added that the merger is subject to several statutory and regulatory approvals, including those from the Reserve Bank of India, Co...
- PVR-INOX merger gets clearance from BSE and NSEOn March 27 this year, PVR and INOX Leisure announced a merger deal to create the largest multiplex chain in the country with a network of ...
- Sebi disposes of adjudication proceedings against Axis Capital in SpiceJet matterIt was alleged that Axis Capital (formerly known as Enam Securities) had amended the Share Purchase Agreement (SPA) on October 5, 2010, aft...
- USFDA issues warning letter to Cipla for Goa manufacturing facilityDrug firm Cipla Ltd said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa. The...
- Aurobindo Pharma, Glenmark crack on USFDA observationsAurobindo Pharma plunged 19% after USFDA flagged lack of good manufacturing practices at the Telangana plant.
- Manpasand Beverages receives letter of caution from SebiThe company has disclosed incorrect information in respect of the educational qualification of Bipin Rathod
- Lupin slumps to 4-year low as USFDA issues warning letter for Goa, Indore plantsThe warning letter was issued on Monday for Pithampur unit II of Indore and its Goa plant.
- Lupin gets warning letter from USFDA for Goa, Indore unitsThe company upholds quality and compliance issues with utmost seriousness and remains fully committed to be compliant with cGMP quality sta...
- USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
- USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
- Sun Pharma trades higher after falling 8% in past four sessionsSun Pharma on Wednesday said the US regulator had issued an observation letter after the completion of inspection of its Halol facility.
- FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
- USFDA issues warning letter to Wockhardt's UK facilityThe significant violations included non-adherence to appropriate written procedures that are designed to prevent contamination of drugs.
- Ipca Labs gets warning letter from USFDA for 3 plantsIpca Laboratories has received warning letter from the US health regulator for three facilities on which the regulator had earlier imposed ...
- USFDA lifts ban on Dr Reddy's Laboratories' Mexico plantDrug firm Dr Reddy's Laboratories today said the US health regulator has lifted an import alert issued on its Mexico-based subsidiary.
Load More
